Cover Image
市場調查報告書

歐洲的感染疾病市場 - 從終端用戶的觀點:器具及試劑的市場規模、市場趨勢、製造商的佔有率

Infectious Diseases Market Monitor in Europe: details from end user perspective: market size, trends and manufacturer shares for instruments and reagents segmented by technology (Immunoassay, microbiology, molecular)

出版商 data information intelligence GmbH 商品編碼 339355
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的感染疾病市場 - 從終端用戶的觀點:器具及試劑的市場規模、市場趨勢、製造商的佔有率 Infectious Diseases Market Monitor in Europe: details from end user perspective: market size, trends and manufacturer shares for instruments and reagents segmented by technology (Immunoassay, microbiology, molecular)
出版日期: 2015年05月01日 內容資訊: 英文
簡介

本報告提供歐洲的感染疾病的實驗室診斷市場相關調查、分析物及各技術的市場規模、成長預測、競爭環境等彙整資料。

主要的技術類別

  • 免疫測量
  • 分子診斷
  • 微生物檢驗

詳細類別

  • Elisa
  • EIA
  • 側流
  • 質譜分析
  • POC
  • 定序

目錄

  • 臨床診斷實驗室的總數:各種類
    • 小規模醫院
    • 中規模醫院
    • 大規模醫院
    • 獨立型 (私人) 實驗室
  • 各檢驗的實施趨勢
    • 微生物檢驗的實施實驗室數
    • 實施實驗室數:各檢驗類型
      • 腺病毒
      • HBV定性
      • HCV定性
      • HIV定性
      • HPV
      • HSV 1 / 2
      • 流感A/B
      • RSV
      • C. diff (梭狀桿菌)
      • CT
      • NG (淋菌 )
      • GAS (A群鏈球菌)
      • GBS (B群鏈球菌)
      • MRSA (抗藥性金黃色葡萄球菌)
      • MTB (結核分枝桿菌)
      • MG (生殖支原體)
      • UU (尿漿菌)
      • 曲狀桿菌
      • 沙門菌
      • 赤痢菌屬
      • TV (陰道毛滴蟲屬)
目錄

This report provides highly granular lab based data on market size, growth and competitive landscape per analyte and technology. Main technology categories are Immunoassays, Molecular and Microbiology. Analysis for sub-categories such as Elisa, EIA, Lateral Flow, Mass Spectronomy, POC or Sequencing, is possible. The market size is defined by the number of labs testing the relevant analyte, segmented by hospitals and private labs and test volumes. Market shares are available for platforms and reagents by installations and also by test volume. This report is a unique business planning tool that helps to prioritize regional sales activities, define realistic sales targets, keep track of competitor's activities by understanding market shares , identify potential to partner or merge with and compare customer segment performance. dii is an international market research company entirely specialized in diagnostics. The survey has been designed in collaboration with key industry.

Table of Contents

  • • Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs
  • • Number of microbiology labs, # of lab performing test by test types: Adenovirus, HBV Qualitative, HCV Qualitative, HIV Qualitative, HPV, HSV 1 / 2, Influenza A/B, RSV, C. diff, CT, NG (Neisseria gonorrhoeae), GAS (Group A Streptococcus), GBS (Group B Streptococcus), MRSA (Methicillin-resistant Staphylococcus aureus), MTB (Mycobacterium tuberculosis), MG (Mycoplasma genitalium), UU (Ureaplasma urealyticum), Campylobacter, Salmonella, Shigella, TV (Trichomonas vaginalis).
Back to Top